{ "cik": 1326190, "cik_padded": "0001326190", "entityName": "Altimmune, Inc.", "fiscal_years": [ { "accn": "0001326190-26-000018", "filed": "2026-03-06", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11000.0, "cash": 43760000.0, "eps_diluted": -1.0, "free_cash_flow": -67546000.0, "net_income": -88093000.0, "operating_cash_flow": -67535000.0, "operating_income": -94489000.0, "revenue": 41000.0, "stockholders_equity": 224892000.0, "total_assets": 279929000.0, "total_liabilities": 55037000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.24472635754050834, "revenue_growth_yoy": 1.05, "roa_avg2y": -0.42025594237122377, "roa_period_end": -0.3146976554769245, "roe_avg2y": -0.5057003444316878, "roe_period_end": -0.39171246642833 } }, { "accn": "0001326190-26-000018", "filed": "2026-03-06", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 36926000.0, "eps_diluted": -1.34, "net_income": -95059000.0, "operating_cash_flow": -79848000.0, "operating_income": -103172000.0, "revenue": 20000.0, "stockholders_equity": 123508000.0, "total_assets": 139306000.0, "total_liabilities": 15798000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12791074262395957, "revenue_growth_yoy": -0.9530516431924883, "roa_avg2y": -0.5432781057648894, "roa_period_end": -0.6823754899286463, "roe_avg2y": -0.5985951191252082, "roe_period_end": -0.7696586455938078 } }, { "accn": "0001326190-26-000018", "filed": "2026-03-06", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 47000.0, "cash": 135117000.0, "eps_diluted": -1.66, "free_cash_flow": -75857000.0, "net_income": -88447000.0, "operating_cash_flow": -75810000.0, "operating_income": -95929000.0, "revenue": 426000.0, "stockholders_equity": 194099000.0, "total_assets": 210640000.0, "total_liabilities": 16541000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08521939834826557, "roa_avg2y": -0.42362920530308834, "roa_period_end": -0.4198965058868211, "roe_avg2y": -0.46625653677462886, "roe_period_end": -0.45567983348703495 } }, { "accn": "0001326190-25-000015", "filed": "2025-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 126000.0, "cash": 111097000.0, "eps_diluted": -1.81, "free_cash_flow": -62712000.0, "net_income": -84713000.0, "operating_cash_flow": -62586000.0, "operating_income": -87740000.0, "stockholders_equity": 185293000.0, "total_assets": 206928000.0, "total_liabilities": 21635000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11676102173314697, "roa_avg2y": -0.39790696418212607, "roa_period_end": -0.40938394030773995, "roe_avg2y": -0.44072231991426225, "roe_period_end": -0.4571840274592132 } }, { "accn": "0001326190-24-000010", "filed": "2024-03-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12117000.0, "cash": 190301000.0, "eps_diluted": -2.35, "free_cash_flow": -90355000.0, "net_income": -97090000.0, "operating_cash_flow": -78238000.0, "operating_income": -96914000.0, "revenue": 4410000.0, "stockholders_equity": 199135000.0, "total_assets": 218865000.0, "total_liabilities": 19730000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0990785145755392, "roa_avg2y": -0.4185092263837553, "roa_period_end": -0.4436067895734814, "roe_avg2y": -0.45688229245831286, "roe_period_end": -0.4875586913400457 } }, { "accn": "0001558370-22-003659", "filed": "2023-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 203957.0, "cash": 115917807.0, "eps_diluted": -1.91, "free_cash_flow": -34509772.0, "net_income": -49044477.0, "operating_cash_flow": -34305815.0, "operating_income": -54798741.0, "stockholders_equity": 225876000.0, "total_assets": 245115213.0, "total_liabilities": 19238890.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08517456480546849, "roa_avg2y": -0.3278667446830044, "roa_period_end": -0.20008744622472696, "roe_avg2y": -0.36142353325827997, "roe_period_end": -0.21713009350262977 } }, { "accn": "0001564590-21-008422", "filed": "2022-03-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1227.0, "cash": 8962686.0, "free_cash_flow": -9603224.0, "net_income": -20520131.0, "operating_cash_flow": -9601997.0, "operating_income": -21464935.0, "stockholders_equity": 45520146.0, "total_assets": 54058020.0, "total_liabilities": 8537874.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.18756253549801882, "roa_avg2y": -0.37717860842605383, "roa_period_end": -0.37959457264620494, "roe_avg2y": -0.43737691392741584, "roe_period_end": -0.45079229315301406 } }, { "accn": "0001564590-21-008422", "filed": "2021-02-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 975407.0, "cash": 33718713.0, "free_cash_flow": -10364315.0, "net_income": -39171152.0, "operating_cash_flow": -9388908.0, "operating_income": -42834410.0, "stockholders_equity": 48312566.0, "total_assets": 54750542.0, "total_liabilities": 6437976.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13325675974238255, "roa_avg2y": -0.6651537651206171, "roa_period_end": -0.7154477484442071, "roe_avg2y": -0.8932133504356122, "roe_period_end": -0.8107859971668655 } }, { "accn": "0001564590-20-013377", "filed": "2020-03-27", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 112441.0, "cash": 8769465.0, "free_cash_flow": -20326520.0, "net_income": -46425390.0, "operating_cash_flow": -20214079.0, "operating_income": -52045259.0, "stockholders_equity": 39395823.0, "total_assets": 63030200.0, "total_liabilities": 14352610.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.36431806488723434, "roa_avg2y": -0.9154125037396283, "roa_period_end": -0.7365578722580605, "roe_avg2y": -1.2967416264084262, "roe_period_end": -1.1784343228468663 } }, { "accn": "0001564590-19-010429", "filed": "2019-04-01", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 124955.0, "cash": 2876113.0, "eps_diluted": 2.95, "net_income": -11086812.0, "operating_income": -11091663.0, "stockholders_equity": 32207323.0, "total_assets": 38400335.0, "total_liabilities": 6193012.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.19228583511892622, "roa_period_end": -0.2887165437489022, "roe_period_end": -0.34423264547630983 } }, { "accn": "0001144204-17-014528", "filed": "2017-03-14", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares" }, "fundamentals": { "capex": 86507.0, "eps_diluted": -0.05 }, "period_end": "2015-12-31", "ratios": {} }, { "accn": "0001144204-17-014528", "filed": "2017-03-14", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.17 }, "period_end": "2014-12-31", "ratios": {} }, { "accn": "0001144204-13-014894", "filed": "2013-03-14", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD" }, "fundamentals": { "operating_cash_flow": -2322906.0 }, "period_end": "2012-12-31", "ratios": {} }, { "accn": "0001144204-12-013807", "filed": "2012-03-08", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "revenue": "USD" }, "fundamentals": { "revenue": 24266274.0 }, "period_end": "2011-12-31", "ratio_units": { "revenue_growth_yoy": "ratio" }, "ratios": { "revenue_growth_yoy": 0.1558888528197039 } }, { "accn": "0001144204-12-013807", "filed": "2012-03-08", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "revenue": "USD" }, "fundamentals": { "revenue": 20993605.0 }, "period_end": "2010-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001326190-26-000018", "filed": "2026-03-06", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001326190.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001326190.json" }, "ticker": "ALT" }